As of January 22, 2025, Laurus Labs (LAURUSLABS.NS) has a market cap of $3.56 billion USD. According to our data, Laurus Labs is ranked No.3214 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.56 B |
-5.28%
|
Dec 31, 2024 | $3.76 B |
40.34%
|
Dec 29, 2023 | $2.68 B |
15.19%
|
Dec 30, 2022 | $2.33 B |
-30.10%
|
Dec 31, 2021 | $3.33 B |
53.28%
|
Dec 31, 2020 | $2.17 B |
400.06%
|
Dec 31, 2019 | $0.43 B |
-2.74%
|
Dec 31, 2018 | $0.45 B |
-29.86%
|
Dec 29, 2017 | $0.64 B |
13.18%
|
Dec 30, 2016 | $0.56 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$365.09 B |
95.523 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Novo Nordisk
NVO
|
$335.53 B |
64.154 B
|
Denmark
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
CSL
CSL.AX
|
$82.06 B |
-0.963 B
|
Australia
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Zoetis
ZTS
|
$75.07 B |
-0.001 M
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.96 B |
0.455 B
|
Japan
|
Market Cap | = | LAURUSLABS.NS Stock Price | * | LAURUSLABS.NS Shares Outstanding |
= | $6.60 | * | 0.54 B | |
= | $3.56 B |